Intrexon Corporation (NYSE:XON), a leader in synthetic biology, announced it has formed a new Exclusive Channel Collaboration (ECC) with ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), a …
Quick SPDR S&P 500 ETF Trust (NYSE ARCA:SPY) forecast update: Back on November 10th 2014 we predicted a spring 2015 high of 2181 …
Some biopharma business development teams had a sleepless weekend. Four healthcare-related acquisitions were announced in quick succession on Monday morning, totaling about $18 billion …
